Tag Archives: Pre-Symptomatic Diagnosis of Dementia

New Drugs for Dementia (POST Note PN 535)

Posted on August 29, 2016 by Dementia and Elderly Care News

Summary The Parliamentary Office of Science and Technology (POST) has produced a briefing outlining some of the challenges in developing new drugs for dementia, explained in the context of ongoing UK and international research programmes. There is an extensive bibliography, … Continue reading →

Posted in Alzheimer's Society, Alzheimer’s Research UK, Antipsychotics, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Models of Dementia Care, National, Pharmacological Treatments, Quick Insights, Statistics, UK, Universal Interest | Tagged Academic Institutes in the UK, Academy of Social Sciences, Aducanumab (Biogen), Alzheimer’s Association, Alzheimer’s Research UK’s Drug Discovery Alliance, Behavioural and Psychological Symptoms of Dementia (BPSD), Big Data, Big Data Funding and Research, Big Pharma, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, BPSD: Behavioral and Psychological Symptoms of Dementia, British Psychological Society (BPS), Co-ordination and Data Analytics, Cognitive Health in Ageing Register for Investigations, Collaborative Projects, Collaborative Research, Dementia Consortium, Dementia Risk Prevention, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), DPUK: Dementias Platform UK, Drug Discovery Alliance, Drug Licensing Approval, Drugs for BPSD, Drugs for Cognitive Symptoms of Cognitive Decline and Dementia, EAMS: Early Access to Medicines Scheme, Early Access to Medicines Scheme, Effective Non-Drug Interventions, Etanercept, European Prevention of Alzheimer's Dementia Consortium (EPAD), European Prevention of Alzheimer’s Dementia Consortium, Identification of People At Risk of Dementia, International Collaborations, International Programmes, International Research, Join Dementia Research, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, New Drugs for Dementia (POST Note PN 535), NIHR Clinical Research Network, Observations & Trials in Dementia Research, Parliament, Parliamentary Office of Science & Technology, Parliamentary Office of Science & Technology (POST), Participation in Research, Patient Access to New Drugs, Pharmaceutical Industry, Pioglitazone, POST: Parliamentary Office of Science & Technology, Pre-Symptomatic Diagnosis of Dementia, Preclinical Biomarkers and Dementia, Preclinical Indicators and Dementia, Prevention, Public Participation in Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Mapping, Research Networks, Solanezumab (Eli Lilly), Symptom-Modifying Drugs for Dementia, UK Dementia Research Institute, UK Parliament, UK Patient Recruitment Initiatives, Verubecestat (Merck), Well-Being and Health for People With Dementia (WHELD) Program | Leave a comment

First Recorded UK Case of Assisted Suicide for Dementia (BBC News / JRCPE)

Posted on June 2, 2013 by Dementia and Elderly Care News

Summary The first case has been reported of a British person electing to end his own life at the Dignitas facility in Zürich (Switzerland) after being diagnosed as having the early stages of dementia. The 83-year-old was assessed to be mentally competent to make the decision. Reactions … Continue reading →

Posted in Alzheimer's Society, BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Social Workers (mostly), In the News, National, Patient Care Pathway, Quick Insights, UK, Universal Interest | Tagged Alzheimer’s Disease Biomarkers, Assessment and Diagnosis, Assisted Dying, Assisted Dying and the Law: International Comparisons, Assisted Suicide, Assisted Suicide for Dementia, BBC Health News, Belgium, Biomarkers, Canada, Care Not Killing Alliance, Colombia, Conversion to Dementia From Prodromal Disease, Declaration of Helsinki, Dementia Diagnosis, Diagnosis of Alzheimer's Disease, Diagnosis of Dementia, Diagnosis Rates, Dignitas (Zurich), Dignity in Dementia, Disclosure of Diagnosis, Dutch Regional Review Committees, Early Dementia Diagnosis: Risk of Suicide and Euthanasia, Early Diagnosis, Ethical Dilemmas, Ethics and Decision-Making, Euthanasia and the Law: International Comparisons, Experiences of Diagnosis, Living and Dying with Alzheimer's (BBC Stories), Luxembourg, Medical Ethics, Netherlands, Post-Diagnosis Support, Pre-Emptive Suicide, Pre-Symptomatic Diagnosis of Alzheimer’s Disease, Pre-Symptomatic Diagnosis of Dementia, Prodromal Alzheimer's Disease, Protection of Research Participants, Rational Suicide, Rational Suicide and Dementia, Recent Diagnosis, Safeguarding, Safeguarding of Vulnerable Adults (SOVA), Safeguarding Older People, Stigma, Suicide, Unintended Consequences, University of New South Wales, World Medical Association: WMA Declaration of Helsinki | Leave a comment

Tag Archives: Pre-Symptomatic Diagnosis of Dementia

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites